Login

Oxford Biomedica Eyes £58.8 Million Oxford Sale-And-Leaseback

Life Sciences Group Has Mandated CBRE To Find Buyer For HQ
The building at Windrush Court. (CoStar)
The building at Windrush Court. (CoStar)
CoStar News
August 5, 2022 | 1:47 P.M.

Oxford Biomedica has appointed CBRE to sell and leaseback its headquarters in Oxford, seeking £58.8 million or a 4.25% net initial yield.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE